Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
18.18
-3.06 (-14.41%)
At close: Oct 30, 2026, 4:00 PM EST
18.17
-0.01 (-0.06%)
Pre-market: Nov 2, 2026, 8:01 AM EST
Mineralys Therapeutics Employees
Mineralys Therapeutics had 76 employees as of December 31, 2025. The number of employees increased by 25 or 49.02% compared to the previous year. That makes Mineralys Therapeutics the 33,045th largest employer in the world and 4,314th in the United States.
Employees
76
Change (1Y)
25
Growth (1Y)
49.02%
Revenue / Employee
n/a
Profits / Employee
-$4,599,684
Market Cap
1.61B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 76 | 25 | 49.02% |
| Dec 31, 2024 | 51 | 23 | 82.14% |
| Dec 31, 2023 | 28 | 16 | 133.33% |
| Dec 31, 2022 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Novavax | 749 |
| Immunocore Holdings | 524 |
| Replimune Group | 465 |
| Ocular Therapeutix | 325 |
| Nuvation Bio | 305 |
| UroGen Pharma | 300 |
| Structure Therapeutics | 281 |
MLYS News
- 4 days ago - Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026 - GlobeNewsWire
- 5 days ago - Mineralys Therapeutics announces full results from Explore-CKD trial - TheFly
- 5 days ago - Mineralys Therapeutics Announces Publication of Phase 2 Explore-CKD Trial Results for Lorundrostat in Kidney International - GlobeNewsWire
- 10 days ago - Mineralys Therapeutics Presents New Lorundrostat Data in Participants with Hypertension and Chronic Kidney Disease at ASN Kidney Week 2026 - GlobeNewsWire
- 13 days ago - Mineralys Therapeutics Expands its Board of Directors with the Appointments of Kristine Peterson and Lonnel Coats - GlobeNewsWire
- 21 days ago - Mineralys Therapeutics initiated with a Neutral at UBS - TheFly
- 23 days ago - Mineralys Therapeutics presents new analysis from Launch-HTN trial - TheFly
- 24 days ago - Mineralys Therapeutics Presents New Data for Lorundrostat at the American Heart Association Hypertension Scientific Sessions 2026 - GlobeNewsWire